WebRezlidhia – FEP MD Fax Form Revised 3/17/2024 Send completed form to: Service Benefit Plan Prior Approval P.O. Box 52080 MC 139 Phoenix, AZ 85072-2080 Attn. Clinical Services Fax: 1-877-378-4727 Message: Attached is a Prior Authorization request form. WebREZLIDHIA™ is for adults with mIDH1+ relapsed or refractory acute myeloid leukemia (AML). See Full Prescribing Information, including Boxed WARNING & Medication Guide.
Rezlidhia (olutasidenib) dosing, indications, interactions, …
WebCigna covers olutasidenib (Rezlidhia™) as medically necessary when the following criteria are met for FDA Indications or Other Uses with Supportive Evidence: Prior Authorization is recommended for prescription benefit coverage of Rezlidhia. All approvals are provided for the duration noted below. Webclonidine. olutasidenib will decrease the level or effect of clonidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Avoid … fox channel 7 austin texas
FDA approves olutasidenib for relapsed or refractory acute myeloid
WebDec 1, 2024 · The Food and Drug Administration (FDA) has approved Rezlidhia (olutasidenib) for adults with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation, as detected by the Abbott RealTime IDH1 Assay — a test that was approved alongside the drug. The approval was based off findings from the phase … WebDec 7, 2024 · Rezlidhia FDA Approval History. Last updated by Judith Stewart, BPharm on Dec 7, 2024.. FDA Approved: Yes (First approved December 1, 2024) Brand name: Rezlidhia Generic name: olutasidenib Dosage form: Capsules Company: Forma Therapeutics Treatment for: Acute Myeloid Leukemia Rezlidhia (olutasidenib) is an … WebDec 20, 2024 · Olutasidenib (FT-2102) is a selective and potent isocitrate dehydrogenase-1 (IDH1) inhibitor approved by the FDA in December 2024.5,6 It is indicated for the treatment of relapsed or refractory acute myeloid leukemia (AML) in patients with a susceptible IDH1 mutation as determined by an FDA-approved test.5 IDH1 mutations are common in … fox channel columbus ohio